Alliance Pharma to buy Cambridge Laboratories' assets
This article was originally published in Scrip
Executive Summary
Alliance Pharma of the UK has agreed to buy the majority of the remaining assets of privately held Cambridge Laboratories for between £14.3 million and £16.4 million plus the value of inventory held at completion, which is expected on February 22nd.